Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 8Breast Neoplasms 4Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Psychological Well-Being 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Motor Activity 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Leukemia 2Hodgkin Disease 2Colorectal Neoplasms 2Colonic Neoplasms 2Cognitive Dysfunction 2Brain Neoplasms 2Weight Loss 1Ventricular Dysfunction, Left 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Specific Learning Disorder 1Sarcoma 1Prostatic Neoplasms 1Pharyngeal Neoplasms 1Pancreatic Neoplasms 1

Interventions

Nebivolol 1Methods 1Exercise 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ventricular Dysfunction, Left × Methods × Lymphoid × Clear all
NCT04892667 2025-08-13

DETECT

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting
128 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡